Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: The oral glucose tolerance test (OGTT) is a cumbersome test that is time consuming, labour intensive and often poorly tolerated by pregnant women. To date, glycosylated haemoglobin (HbA1c) is the most accepted measure of chronic glycaemia outside of pregnancy. HbA1c is an uncomplicated test, less time consuming, does not require any specific patient preparation and is considered straightforward compared with the OGTT. Therefore, we prospectively tested the utility of the HbA1c when used as a screening tool in pregnancy for gestational diabetes mellitus (GDM). SETTINGS: Primary health care. Single tertiary referral centre, Tasmania, Australia. PARTICIPANTS: A direct comparison between HbA1c levels and the OGTT results in pregnant women, tested concurrently at the 24-28 gestational week, was undertaken. A full profile of 480 pregnant women during the period from September 2012 to July 2014 was completed. Median and mean age of participants was 29 years (range 18-47 years). INTERVENTIONS: A simultaneous prospective assessment of HbA1c versus standard OGTT in a cohort of consecutive pregnant women presenting to our institute was performed. RESULTS: The number of women who had GDM according to OGTT criteria was 57, representing 11.9% of the evaluated 480 pregnant women. Using a cut-off value for HbA1c at 5.1% (32 mmol/mol) for detecting GDM showed sensitivity of 61% and specificity of 68% with negative predictive value (NPV) of 93%, versus sensitivity of 27% and specificity of 95% with NPV of 91% when using HbA1c cut-off value of 5.4% (36 mmol/mol). CONCLUSIONS: Our results suggest that pregnant women with an HbA1c of≥5.4% (36 mmol/mol) should proceed with an OGTT. This may result in a significant reduction in the burden of testing on both patients and testing facility staff and resources. Further investigations are required to integrate and optimise the HbA1c as a single, non-fasting, screening tool for GDM. TRIAL REGISTRATION NUMBER: ACTRN12611000739910.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of A1C at 24 -28 weeks of gestation as a screening test for GDM does not function as well as the GLT (224).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [224]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of A1C at 24-28 weeks of gestation as a screening test for GDM does not function as well as the GLT (206).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [206]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Li, S., Shin, H. J., Ding, E. L., & van Dam, R. M. (2009) · JAMA · doi:10.1001/jama.2009.976 · Cited by 991
Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus
Butte, N. F. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1256s · Cited by 826
Pregnancy Outcomes in Women With Gestational Diabetes Compared With the General Obstetric Population
Casey, B. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00542-5 · Cited by 437 · cited 1×
“INTRODUCTION Pregnancies affected by gestational diabetes mellitus (GDM) are at risk of developing a number of serious obstetric complications such as fetal growth abnormalities, shoulder dystocia, birth injury, prematurity and increased Caesarean section rate, as well as having long-term implications for the wellbein…”
BackgroundShort-term variability in measures of glycemia and implications for the classification of diabetes
Selvin, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1545 · Cited by 402
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
“A systematic review for the U.S. Preventive Services Task Force compared GLT cutoffs of 130 mg/dL (7.2 mmol/L) and 140 mg/dL (7.8 mmol/L) (241).”
MethodInfluential2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
“The American College of Obstetricians and Gynecologists (ACOG) recommends any of the commonly used thresholds of 130, 135, or 140 mg/dL for the 1-h 50-g GLT (69).”
MethodInfluential2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603
“The panel recommended a twostep approach to screening that used a 1-h 50-g glucose load test (GLT) followed by a 3-h 100-g OGTT for those who screened positive.”
MethodInfluential2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Gestational diabetes mellitus - A metabolic and reproductive disorder
Choudhury, A. A., & Devi Rajeswari, V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112183 · Cited by 442
Data sharing in PLOS ONE: An analysis of Data Availability Statements
Federer, L. M., Belter, C. W., Joubert, D. J., Livinski, A., Lu, Y.-L., Snyders, L. N., & Thompson, H. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194768 · Cited by 208
Pillay, J., Donovan, L., Guitard, S., Zakher, B., Gates, M., Gates, A., Vandermeer, B., Bougatsos, C., Chou, R., & Hartling, L. (2021) · JAMA · doi:10.1001/jama.2021.10404 · Cited by 99
The Emerging Role of Biomarkers in the Diagnosis of Gestational Diabetes Mellitus
Rodrigo, N., & Glastras, S. J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7060120 · Cited by 84
“4% has been demonstrated to have 95% specificity, 27% specificity, and a negative predictive value of 91% for GDM at 24–28 weeks of gestation [32].”
BackgroundGür, E. Y., & Apay, S. E. (2020) · Midwifery · doi:10.1016/j.midw.2020.102856 · Cited by 71
Is first-trimester HbA1c useful in the diagnosis of gestational diabetes?
Benaiges, D., Roux, J. A. F., Marcelo, I., Mañé, L., Rodríguez, M. Á., Navarro, X., Chillarón, J. J., Llauradó, G., Gortazar, L., Pedro‐Botet, J., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.019 · Cited by 64
Jiang, B., Zhang, J., Sun, X., Yang, C., Cheng, G., Xu, M., Li, S., & Wang, L. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-021-03195-5 · Cited by 60
“As described in the previous studies, dipocytokine [18], HbA1c [19, 20], glycosylated haemoglobin [21], Adiponectin and 1,5 Anhydroglucitol have been recommended as the biomarker for screening early GDM [22].”
MethodThe Hidden Impact of Gestational Diabetes: Unveiling Offspring Complications and Long-Term Effects
Bekai, E. A., Beaini, C. E., Kalout, K., Safieddine, O., Semaan, S., Sahyoun, F., Ghadieh, H. E., Azar, S. T., Kanaan, A., & Harb, F. (2025) · Life · doi:10.3390/life15030440 · Cited by 75
“An HbA1c level >5.4% suggests an increased risk of developing GDM, warranting an OGTT for confirmation [87].”
Influentiald-Ribose contributes to the glycation of serum protein
Chen, Y., Yu, L., Wang, Y., Yan, W., Xu, Y., He, T., & He, R. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.05.005 · Cited by 63
Renz, P. B., Chume, F. C., Timm, J. R. T., Pimentel, A. L., & Camargo, J. L. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-1191 · Cited by 54
“8% (40 mmol/ mol) [27, 44, 45, 49], totaling 4160 pregnant women.”
InfluentialPoint-of-care diagnostics to improve maternal and neonatal health in low-resource settings
Majors, C. E., Smith, C. A., Natoli, M. E., Kundrod, K. A., & Richards-Kortum, R. R. (2017) · Lab on a Chip · doi:10.1039/c7lc00374a · Cited by 57
Kim, W., Park, S. K., & Kim, Y. L. (2019) · PLOS ONE · doi:10.1371/journal.pone.0225955 · Cited by 52
Edelson, P. K., James, K. E., Leong, A., Arenas, J., CAYFORD, M., Callahan, M. J., Bernstein, S. N., Tangren, J. S., Hivert, M., Higgins, J. M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa053 · Cited by 53
An Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review
Minschart, C., Beunen, K., & Benhalima, K. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s287121 · Cited by 48
First trimester glycosylated hemoglobin as a predictor of gestational diabetes mellitus
Arbib, N., Shmueli, A., Salman, L., Krispin, E., Toledano, Y., & Hadar, E. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12794 · Cited by 35
Hong Yi, D. U., Jiang, H., Karmin, O., Chen, B., Xu, L., Liu, S. P., Yi, J. P., He, G. S., & Qian, X. (2017) · PubMed · doi:10.3967/bes2017.119 · Cited by 36
Mora-Ortiz, M., & Rivas‐García, L. (2024) · Open Research Europe · doi:10.12688/openreseurope.18026.1 · Cited by 38
The utility of HbA1c combined with haematocrit for early screening of gestational diabetes mellitus
Wu, K., Cheng, Y., Li, T., Ma, Z., Liu, J., Zhang, Q., & Cheng, H. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0314-9 · Cited by 32
“The low sensitivity of 27% of HbA1c becomes a hurdle in standardizing such a test in pregnancy [27], and women may not benefit from early screening in pregnancy.”
BackgroundEpidemiology of prediabetes and diabetes in Namibia, Africa: A multilevel analysis
Adekanmbi, V., Uthman, O. A., Erqou, S. A., Echouffo-Tcheugui, J. B., Harhay, M. N., & Harhay, M. O. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12829 · Cited by 33
Punnose, J., Malhotra, R. K., Sukhija, K., Mathew, A., Sharma, A., & Choudhary, N. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107953 · Cited by 34
Amaefule, C. E., Sasitharan, A., Kalra, P., Iliodromoti, S., Huda, M. S. B., Rogozińska, E., Zamora, J., & Thangaratinam, S. (2020) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000648 · Cited by 31
dʼEmden, M. C., McLeod, D. S. A., Ungerer, J. P. J., Appleton, C. A., & Kanowski, D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243192 · Cited by 22
“Many patients do not tolerate the POGTT, with significant rates of abdominal discomfort, nausea and vomiting invalidating the test [5, 6].”
BackgroundReliability of glycosylated hemoglobin in the diagnosis of gestational diabetes mellitus
Rayis, D. A., Ahmed, A. B. A., Sharif, M. E., ElSouli, A., & Adam, I. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23435 · Cited by 23
Glycated Hemoglobin and Red Blood Cell Indices in Non-diabetic Pregnant Women
Abass, A., Musa, I. R., Rayis, D. A., Adam, I., & Gasim, G. I. (2017) · Clinics and Practice · doi:10.4081/cp.2017.999 · Cited by 24
Braga, F. O., Negrato, C. A., da Matta, M. D. F. B., Carneiro, J. R. I., & Gomes, M. B. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000099 · Cited by 19
“0%, which was also the cut-off point we found (21).”
BackgroundInfluentialHM-Chromanone Ameliorates Hyperglycemia and Dyslipidemia in Type 2 Diabetic Mice
Park, J. E., Son, J., Seo, Y., & Han, J.-S. (2022) · Nutrients · doi:10.3390/nu14091951 · Cited by 17
“5%, and HbA1c increases by 2–3 times in the presence of diabetes [35].”
BackgroundLee, J., Lee, H., & Lee, J. (2018) · Nutrition Research and Practice · doi:10.4162/nrp.2018.12.6.469 · Cited by 16
“In addition, HbA1c accounts for 3-6% of normal hemoglobin and HbA1c levels show 2-3 fold increase in patients with diabetes [47].”
BackgroundMárquez, J. M. M., Riejos, P. F., Rodríguez, C. G., & Sánchez‐Margalet, V. (2019) · Annals of Laboratory Medicine · doi:10.3343/alm.2019.39.6.524 · Cited by 16
The association between second trimester ultrasound fetal biometrics and gestational diabetes
Andersen, A. S., Rathcke, S. L., Christensen, T. T., & Sørensen, A. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.07.015 · Cited by 14
Ahmadi, S., Rabiee, N., & Rabiee, M. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666180607075550 · Cited by 14
Dubey, D., Kunwar, S., & Gupta, U. (2019) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13916 · Cited by 15
“Conversely, Soumya et al.18 and Khalafallah et al.11 reported a lower prevalence of GDM at 9% and 11.9%, respectively, using the OGTT criteria.”
BackgroundInfluentialXiang, L.-L., Chen, C., Wang, Q., Zhu, Y., Chen, Y., & Zeng, Y. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06528-x · Cited by 13
“The accuracy of HbA1c as a screening tool in pregnancy has been extensively studied in recent decades, but the results are inconsistent [7, 13, 35, 36].”
BackgroundResultInfluentialSu, R., Wu, X., & Ke, F. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s341106 · Cited by 12
Peng, X., Liu, M., Gang, J., Wang, Y., & Ma, X. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06637-7 · Cited by 12
“Another study [34] indicated that Table 4 At 90% sensitivity, the cut-off values, specificity, PPV and NPV of FPG, 1hPG, 2hPG and HbA1c for predicting GDM”
BackgroundOrru, M. I., Nwose, E. U., Nwose, E. U., Bwititi, P., Nwose, E. U., Igumbor, E. O., Bwititi, P., Bwititi, P., Igumbor, E. O., & Igumbor, E. O. (2017) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20175487 · Cited by 11
Xu, C., Han, Z., Li, P., & Li, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6291 · Cited by 11
“Symptoms of GDM include hyperglycemia, glucose intolerance, insulin resistance and fetal maldevelopment (2).”
Ruiz-Hoyos, B. M., Franco, Á. L. L., & Ramírez-Aristizábal, R. A. (2018) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.3056 · Cited by 15
Walker, A. R., & Caughey, A. B. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1716213 · Cited by 11
“The cost of the HbA1c assay and the OGTT including labor were $12 and $34, respectively [14].”
Diagnosis of gestational diabetes during the pandemic: what is the risk of falling through the net?
Ikomi, A., Mannan, S., Simon, G., Khan, R., Smith, S., Robbins, J., Kavanagh, U., & Crone, D. (2020) · Diabetic Medicine · doi:10.1111/dme.14346 · Cited by 10
Assessment of von Willebrand disease and pregnancy outcomes at regional Australian hospitals
Wilson, E., Hanna, F., Hyppa, A., Orlowski, E., Dawar, H. U., Sanga, Z., Dennis, A. E., Pavlov, T., & Khalafallah, A. A. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13562 · Cited by 10
Self-citationPark, J.-E., Yoo, J., & Han, J.-S. (2024) · Nutrients · doi:10.3390/nu16223972 · Cited by 9
“The non-enzymatic and irreversible glycation of hemoglobin continues to occur in cells during this period, resulting in an increase in the concentration of HbA1c [46].”
Amreen, S., Mundkur, A. S., Shetty, A., Vasudeva, A., & Kumar, P. (2018) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20180166 · Cited by 10
“4% should undergo a GTT and this will reduce the burden of universal second trimester screening.(13)”
BackgroundProbiotic therapy as a promising strategy for gestational diabetes mellitus management
Lemos, D. E. D. A., Alves, J. L. D. B., & de Souza, E. L. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2409880 · Cited by 8
“However, GDM could be associated with a reduced ability of the pancreas to carry out this compensatory response, leading to a hyperglycemic condition characterized by pancreatic β-cell dysfunction and an uninterrupted cycle of hyperglycemia and insulin resistance [4,22,23].”
Lo nuevo en diagnóstico y tratamiento de diabetes mellitus gestacional
Artavia, A. L. E., & Vaglio, R. F. (2019) · Revista Medica Sinergia · doi:10.31434/rms.v4i4.180 · Cited by 14
Mousavi, S. N., Kamali, K., Mirbazel, M., & Jameshorani, M. (2017) · PubMed Central · Cited by 7
Widiyana, I. G., Yusa, N. M., & Sugitha, I. M. (2021) · Jurnal Ilmu dan Teknologi Pangan (ITEPA) · doi:10.24843/itepa.2021.v10.i01.p05 · Cited by 5
Lappharat, S., & Liabsuetrakul, T. (2020) · Medicine · doi:10.1097/md.0000000000023161 · Cited by 8
“Owing to its properties and convenience (non-glucose loading and non-fasting), there has been substantial interest in using it as an alternative measurement for GDM screening.([68]) Our review found two studies conducted in India with thresholds of 5.”
BackgroundSun, X., McKeaveney, C., Noble, H. R., O'Hara, H., & Perra, O. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14128 · Cited by 3
“The participating women ’ s average BMI (20.4 – 2.5 – 33.0 – 6.7) was reported in all but two studies 28,29 .”
BackgroundMethodResultInfluentialDiabetes and pregnancy: A call for terminology standardization in clinical practice
Carranza, E. A. A., Casella, J. A. L., & Concepción‐Zavaleta, M. J. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112102 · Cited by 3
Amadi, S. C., Ogu, R., Odum, E. P., Ojule, J. D., Enyindah, C. E., & Ugboma, H. (2021) · Nigerian Medical Journal · doi:10.60787/nmj-62-4-31 · Cited by 3
“[14] In the last decades, Glycosylated haemoglobin (HbA1c), a marker showing the average of plasma glucose in the past eight to twelve weeks,has been endorsed as a diagnostic marker for diabetes mellitus outside pregnancy .”
BackgroundMethodResultInfluentialKs, I. (2018) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v23i2.1145 · Cited by 5
Zolton, J. R., Sjaarda, L. A., Mumford, S. L., Holland, T. L., Kim, K., Flannagan, K. S. J., Yisahak, S. F., Hinkle, S. N., Connell, M. T., White, M. V., et al. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.01.002 · Cited by 2
Assessment of Serum Neuregulin 4 Level and Several Metabolic Parameter in Gestational Diabetes
Bayati, M. M. A. (2023) · International Journal of Research in Medical Sciences & Technology · doi:10.37648/ijrmst.v16i01.012 · Cited by 2
Significance of cardiac and iron profile alteration in diabetic patients
Hasona, N. A. (2017) · Comparative Clinical Pathology · doi:10.1007/s00580-017-2470-y · Cited by 2
“Increasing levels of HbA1c in diabetic patients has revealed the relationship between HbA1c and blood glucose concentrations (American Diabetes Association 2013; Khalafallah et al. 2016).”
BackgroundAntidiabetic and Immunomodulatory Effects of Oleuropein and Vitamin C in Diabetic Male Rats
Mohamed, N. A., Abdou, H. M., & Marzouk, M. M. (2018) · JOURNAL OF ADVANCES IN BIOLOGY · doi:10.24297/jab.v11i0.7689 · Cited by 3
Waites, B. T., Walker, A. R., Skeith, A. E., & Caughey, A. B. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1847073 · Cited by 3
“43) either as a confirmatory test or as a follow-up test at 28weeks gestation if FPG was normal [32,33].”
Munir, S. I., Khalil, N., Khokhar, S. J., & Sayyed, B. (2022) · Pak-Euro Journal of Medical and Life Sciences · doi:10.31580/pjmls.v5i1.2452 · Cited by 1
“It is also more convenient to perform as it doesn’t require pre-test fasting and can be performed during routine antenatal visits (5, 6).”
BackgroundComplex considerations when tendering for HbA1c analysers
Tormey, W. P., Byrne, B., Russell, C., Collier, G., & Sreenan, S. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0948 · Cited by 1
Jose, P., Vani, J., Kommu, P. P. K., Kuruvila, S. K., & Krishnan, L. (2017) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20174743 · Cited by 1
Screening for diabetes in dental settings
(2014) · Dental Abstracts · doi:10.1016/j.denabs.2014.03.039
Hasna, A. (2018) · UMM Institutional Repository (University of Maine at Machias)
Samsuria, I. K. (2019) · UNDIP Institutional Repository (UNDIP-IR) (Diponegoro University)
Pukale, R. S., Jayamma, N., & Nikitha, N. (2019) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2019.035
Raising Question Marks: Diagnostic anomalies with standard Oral Glucose Test
Khan, S. H. (2020) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2020.13.555858
Vijayam, B., Balaji, T., Balaji, M. S., Seshiah, V., & Ganesan, V. K. (2022) · The Journal of Medical Research · doi:10.31254/jmr.2022.8309
Level of glycosylated haemoglobin in the first trimester in cases of gestational diabetes mellitus
Gautam, P., Saha, R., Maharjan, S., & Bhusal, S. (2021) · Journal of Kathmandu Medical College · doi:10.3126/jkmc.v10i4.43867
3º CONGRESSO INTERDISCIPLINAR DA ÁREA MÉDICA
Recima, R. (2022) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v3i1.2557
Kandauda, I. C., Tennakoon, S., Gunathilake, T., & Hansamali, B. G. T. (2023) · Sri Lanka Journal of Medicine · doi:10.4038/sljm.v32i1.352
“Having undiagnosed diabetes mellitus can cause several complications such as abnormalities in fetal growth, prematurity, maternal and fetal morbidity, prone to caesarian sections as well as long-term complications for the mother and the neonate [6,7].”
BackgroundFirst trimester HbA1c as an early predictor of gestational diabetes mellitus
Desai, D., Zutshi, M., & Pitre, D. (2023) · International Journal of Clinical Obstetrics and Gynaecology · doi:10.33545/gynae.2023.v7.i5b.1381
“Furthermore, the recommendation for universal screening has significantly increased the burden of testing [13] .”
BackgroundJadhao, A. N., Vengurlekar, S. G., Shah, M. P., & Pathare, S. S. (2023) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20233884
Zou, K., Wei, C., Huang, Q., Xu, Z., Mao, X., Zhang, H., Zeng, C., Zhang, L., Lin, J., Yi, Y., et al. (2024) · Journal of International Medical Research · doi:10.1177/03000605241245299
“12 In addition, GSP is more suitable than HbA1c for assessing glycemic control in certain situations, such as hemodialysis, 23 anemia, 24 and gestational diabetes.”
MethodHussain, M., Parveen, S., Liaqat, J., Saleem, U., Tarar, S. H., & Mudassir, A. Q. (2024) · Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University · doi:10.48036/apims.v19i4.1016
HbA1c as an early diagnostic marker in gestational diabetes mellitus.
Abbas, S., Khattak, M., Hameed, S., Zahra, F.-T., Saeed, S., & Shabir, R. (2024) · The Professional Medical Journal · doi:10.29309/tpmj/2024.31.05.7993
Uso da hemoglobina glicada no diagnóstico do diabetes gestacional
Andrade, E. C. V., Domingos, H. J. A. B., Sandy, J. E. D. S., de Araújo, L. M. S., Pedra, R. A. V., Nascimento, J. G., Canuto, A. L., & Zimmermmann, J. B. (2025) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e18410.2025
“…HbA1c em 5,1% (32 mmol/mol) para detectar DMG tinha sensibilidade de 61% e especificidade de 68%, com valor preditivo negativo (VPN) de 93%, versus sensibilidade de 27% e especificidade de 95%, com VPN de 91%, ao usar o valor de corte de HbA1c de 5,4% (36 mmol/mol) (KHALAFALLAH A, et al., 2016).”
Jiang, B., Zhang, J., Sun, X., Yang, C., Cheng, G., Xu, M., Li, S., & Wang, L. (2022) · Figshare · doi:10.6084/m9.figshare.17799942
Kotwal, M., Datta, K., Sharma, N., & Kumar, A. (2026) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-026-02349-z
Fu, J. R. (2024) · TSpace (University of Toronto)
Naz, S., Yazdani, N. S., Hoodbhoy, Z. A., Ghebremichael‐Weldeselassie, Y., Mazhar, A., Hotwani, A., Jehan, F., Nisar, M. I., & Iqbal, R. (2026) · BMJ Open · doi:10.64898/2026.06.08.26355138
Metadata
- Authors
- Khalafallah, A., Phuah, E., Al-Barazan, A. M., Nikakis, I., Radford, A., Clarkson, W., Trevett, C., Brain, T., Gebski, V., & Corbould, A.
- Affiliations
- University of Tasmania (AU)
- Launceston General Hospital (AU)
- National Health and Medical Research Council (AU)
- Corresponding author
- Khalafallah, Alhossain
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2016-04
- Volume
- 6
- Issue
- 4
- Pages
- e011059
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC4823451
- OpenAlex
- W2337854077
- Cited by
- 86
- References
- 31
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 6 · 2022: 12 · 2021: 7 · 2020: 12 · 2019: 11 · 2018: 12 · 2017: 9 · 2016: 2
- FWCI
- 14.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- glycosylated haemoglobin, HbA1c, gestational diabetes mellitus, gestational diabetes screening, oral glucose tolerance test, diagnostic accuracy, cut-off values, primary care
- MeSH terms
- Adolescent, Adult, Australia, Blood Glucose, Female, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Mass Screening, Middle Aged, Pregnancy, Primary Health Care, Prospective Studies, Biomarkers, Diabetes, Gestational, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.